glp-1 agonist weight loss mechanism GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes Understand GLP-1/GIP Dual Agonist Tirzepatide

It has been estimated that 12% of the US population has had exposure to a GLP-1RA and 6% are currently using one 11

Wegovy (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to: reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight

Why are we still in need of novel anti-obesity medications

Repurposing Semaglutide and liraglutide for Alcohol Use Disorder

Guidelines are evolving, formularies are shifting, and patient expectations are rising